A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

NCT07466316 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
342
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Children's Oncology Group